Cargando…
Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
BACKGROUND: The aim of the study was to compare drug survival rate of subcutaneous tumor necrosis factor alpha inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients in Hungary. METHODS: This was a retrospective analysis using data collected from 5,647 patients...
Autores principales: | Takacs, Peter, Lathia, Urja, Shin, Janey, Nantel, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342139/ https://www.ncbi.nlm.nih.gov/pubmed/30697037 http://dx.doi.org/10.2147/PPA.S186776 |
Ejemplares similares
-
Impact of adherence to biological agents on health care resource utilization for patients over the age of 65 years with rheumatoid arthritis
por: Lathia, Urja, et al.
Publicado: (2017) -
Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database
por: Bhoi, Peter, et al.
Publicado: (2017) -
Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016) -
Biologic Agents—A Panacea for Inflammatory Arthritis or Not?
por: Ninan, J., et al.
Publicado: (2009) -
Adherence and persistence of subcutaneous biologics delivered through homecare services to a cohort of patients with rheumatoid arthritis
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2017)